Dongwha Pharm, Active Community... Stock Price Up 3.48%.
At this time, posts about Dongwha Pharm are rapidly increasing on portals and stock communities. Today, foreigners have net sold 41,000 shares of Dongwha Pharm, and institutions have net sold 5,000 shares, according to provisional data. Dongwha Pharm is known as a manufacturer and seller of pharmaceuticals (such as Gas Hwal Myung Su and Fusidin).
As of 12:30 PM on the 12th, Dongwha Pharm's stock price is 25,250 KRW, up 3.48% from the previous day, with a trading volume of 2,576,813 shares, which is 47.59% of the 5-day average trading volume. On August 11, Dongwha Pharm was an issue in the market with a "reversal down... 7.26%↓" report.
In addition to Dongwha Pharm, posts by investors are also rapidly increasing regarding Bukwang Pharm (003000), SK Innovation Preferred (096775), and Hanwha Life (088350).
※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
- "Am I Really in the Top 30%?" and "Worried About My Girlfriend in the Bottom 70%"... Buzz Over High Oil Price Relief Fund
- "It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
